SomnoMed Limited (ASX:SOM)
Australia · Delayed Price · Currency is AUD 0.3500
+0.0150 (4.48%)
Sep 16, 2026, 2:50 PM AEST
SomnoMed Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 17.18 | 17.29 | 16.18 | 11.96 | 15.64 |
Cash & Short-Term Investments | 17.18 | 17.29 | 16.18 | 11.96 | 15.64 |
Cash Growth | -0.63% | 6.89% | 35.32% | -23.57% | -25.89% |
Accounts Receivable | 9.58 | 11.19 | 7.05 | 7.53 | 7.65 |
Other Receivables | 2.05 | 2.91 | 1.19 | 1.5 | 1.56 |
Receivables | 11.63 | 14.1 | 8.24 | 9.03 | 9.2 |
Inventory | 7.36 | 7.43 | 6.29 | 4.1 | 3.09 |
Prepaid Expenses | 2.78 | 4.33 | 4.43 | 2.41 | 2.38 |
Total Current Assets | 38.95 | 43.14 | 35.14 | 27.5 | 30.32 |
Property, Plant & Equipment | 12.32 | 13.91 | 11.15 | 12.73 | 9.12 |
Goodwill | 6.54 | 7.05 | 6.34 | 6.49 | 6.04 |
Other Intangible Assets | 1.14 | 1.56 | 2.12 | 2.81 | 2.79 |
Long-Term Accounts Receivable | 0.06 | 0.06 | 0.06 | 0.04 | 0.26 |
Long-Term Deferred Tax Assets | 1.3 | 2.38 | 3.14 | 3.25 | 2.95 |
Long-Term Deferred Charges | 14.7 | 12.88 | 11.85 | 9.67 | 6.62 |
Total Assets | 75 | 80.97 | 69.8 | 62.49 | 58.09 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 6.01 | 6.64 | 3.96 | 12 | 12.59 |
Accrued Expenses | 2.67 | 3.62 | 2.51 | 1.95 | 2.17 |
Current Portion of Long-Term Debt | 0.1 | 0.34 | 0.31 | 0.31 | 4.88 |
Current Portion of Leases | 2.15 | 2.49 | 2.3 | 2.26 | 1.78 |
Current Income Taxes Payable | 1.03 | 1.77 | 0.22 | 0.46 | 1.11 |
Current Unearned Revenue | - | - | - | 0 | 0 |
Other Current Liabilities | 11.31 | 13.72 | 10.65 | 1.38 | 1.25 |
Total Current Liabilities | 23.27 | 28.58 | 19.94 | 18.36 | 23.77 |
Long-Term Debt | 0.31 | 0.45 | 0.71 | 16.36 | 2.01 |
Long-Term Leases | 2.9 | 4.75 | 3.41 | 4.59 | 3.34 |
Pension & Post-Retirement Benefits | 1.12 | 0.81 | 0.72 | 0.79 | 1.18 |
Total Liabilities | 27.6 | 34.58 | 24.78 | 40.09 | 30.31 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 112.2 | 110.23 | 119.96 | 84 | 84 |
Retained Earnings | -80.64 | -77.99 | -74.54 | -62.24 | -54.24 |
Comprehensive Income & Other | 15.85 | 14.15 | -0.4 | 0.64 | -1.98 |
Total Common Equity | 47.4 | 46.39 | 45.02 | 22.4 | 27.79 |
Shareholders' Equity | 47.4 | 46.39 | 45.02 | 22.4 | 27.79 |
Total Liabilities & Equity | 75 | 80.97 | 69.8 | 62.49 | 58.09 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 5.46 | 8.03 | 6.72 | 23.51 | 12.01 |
Net Cash (Debt) | 11.73 | 9.27 | 9.46 | -11.55 | 3.63 |
Net Cash Growth | 26.53% | -2.03% | - | - | -70.22% |
Net Cash Per Share | 0.05 | 0.04 | 0.08 | -0.15 | 0.05 |
Filing Date Shares Outstanding | 219.77 | 216.11 | 216.11 | 99.08 | 82.76 |
Total Common Shares Outstanding | 219.19 | 216.11 | 216.11 | 82.76 | 82.76 |
Working Capital | 15.68 | 14.56 | 15.2 | 9.14 | 6.54 |
Book Value Per Share | 0.22 | 0.21 | 0.21 | 0.27 | 0.34 |
Tangible Book Value | 39.73 | 37.79 | 36.56 | 13.1 | 18.96 |
Tangible Book Value Per Share | 0.18 | 0.17 | 0.17 | 0.16 | 0.23 |
Machinery | 19.03 | 17.79 | 14.82 | 13.96 | 12.41 |
Leasehold Improvements | 1.76 | 1.72 | 1.2 | 1.12 | 0.72 |